Article
The non-cell-autonomous component of ALS: new in vitro models and future challenges.
Biochemical Society transactions - 1 Oct 2014
Ferraiuolo Laura
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting the motor nerves. At present, there is no effective therapy for this devastating disease and only one Food and Drug Administration (FDA)-approved drug, riluzole, is known to moderately extend survival. In the last decade, the field of ALS has made a remarkable leap forward in understanding some of the genetic causes of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
